A Randomized Parallel-Group Comparative Study on the Use of Robotics and Health Exercise Programs for Physical Performance Assessment and Health Promotion in Community Residents

A Study on the Use of Robotics and Health Exercise Programs for the Assessment of Physical Performance and Promotion of Health Among Community Residents: A Randomized Parallel-Group Comparative Trial - Assessment of Physical Performance Using Robotics and Health Exercise Programs: A Randomized Parallel-Group Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000060914

Enrollment

120

Registered

2026-04-01

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Physical exercise LOCOBOT exercise Physical exercise and LOCOBOT exercise Control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility Criteria Residents of Kadogawa Town, Miyazaki Prefecture, who wish to participate in the study will be eligible. Healthy volunteers aged 6 years or older at the time of obtaining informed consent. Individuals with no impairment of physical function, confirmed through assessment of medical history including musculoskeletal disorders and other past illnesses. Individuals who have received a full explanation of the study and have provided written informed consent, given voluntarily by the participant after sufficient understanding of the study; for minors, consent will also be obtained from a legally authorized representative.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Individuals with underlying medical conditions or a history of musculoskeletal surgery. Individuals who are judged by the principal investigator to be unsuitable for participation in this study.

Design outcomes

Primary

Measure	Time frame
The following information will be collected directly from participants at the time of study registration and at baseline and 1, 3, 6, and 12 weeks after the start of the study. Participant characteristics: age, sex, height, weight, body mass index (BMI), and the presence or history of musculoskeletal injuries. Locomo Check: body balance, lower-body flexibility, upper-body flexibility, flexibility of the scapula and hip joint, and upper-body mobility. Locomotive Syndrome Risk Test (Locomo Test): stand-up test and two-step test. Other physical performance tests: single-leg standing test with eyes open and with eyes closed. In addition, participants in the LOCOBOT exercise group (Group B) and the Locotre + jackknife stretch + LOCOBOT exercise group (Group C) will undergo the single-leg standing test with eyes open and closed immediately before and after the LOCOBOT exercise session at 12 weeks after the start of the study.	—

Measure

Time frame

The following information will be collected directly from participants at the time of study registration and at baseline and 1, 3, 6, and 12 weeks after the start of the study. Participant characteristics: age, sex, height, weight, body mass index (BMI), and the presence or history of musculoskeletal injuries. Locomo Check: body balance, lower-body flexibility, upper-body flexibility, flexibility of the scapula and hip joint, and upper-body mobility. Locomotive Syndrome Risk Test (Locomo Test): stand-up test and two-step test. Other physical performance tests: single-leg standing test with eyes open and with eyes closed. In addition, participants in the LOCOBOT exercise group (Group B) and the Locotre + jackknife stretch + LOCOBOT exercise group (Group C) will undergo the single-leg standing test with eyes open and closed immediately before and after the LOCOBOT exercise session at 12 weeks after the start of the study.

—

Countries

Japan

Contacts

Public ContactKanako Nishiduru

Faculty of Medicine, University of Miyazaki Orthopaedic Surgery

kanako_nishiduru@med.miyazaki-u.ac.jp0985850986

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026